ATE88901T1 - Fluorkohlenstoffkette enthaltende antigene konjugate. - Google Patents

Fluorkohlenstoffkette enthaltende antigene konjugate.

Info

Publication number
ATE88901T1
ATE88901T1 AT89101745T AT89101745T ATE88901T1 AT E88901 T1 ATE88901 T1 AT E88901T1 AT 89101745 T AT89101745 T AT 89101745T AT 89101745 T AT89101745 T AT 89101745T AT E88901 T1 ATE88901 T1 AT E88901T1
Authority
AT
Austria
Prior art keywords
fluorocarbon chain
chain containing
containing antigen
antigen conjugates
haptens
Prior art date
Application number
AT89101745T
Other languages
English (en)
Inventor
Rao R Koganty
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Application granted granted Critical
Publication of ATE88901T1 publication Critical patent/ATE88901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89101745T 1988-02-01 1989-02-01 Fluorkohlenstoffkette enthaltende antigene konjugate. ATE88901T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/151,145 US5055562A (en) 1988-02-01 1988-02-01 Fluorocarbon chain-containing antigenic conjugates
EP89101745A EP0327070B1 (de) 1988-02-01 1989-02-01 Fluorkohlenstoffkette enthaltende antigene Konjugate

Publications (1)

Publication Number Publication Date
ATE88901T1 true ATE88901T1 (de) 1993-05-15

Family

ID=22537502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101745T ATE88901T1 (de) 1988-02-01 1989-02-01 Fluorkohlenstoffkette enthaltende antigene konjugate.

Country Status (5)

Country Link
US (1) US5055562A (de)
EP (1) EP0327070B1 (de)
JP (1) JPH01294698A (de)
AT (1) ATE88901T1 (de)
DE (1) DE68906279T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
WO1995029927A2 (en) * 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
US5688295A (en) * 1996-05-08 1997-11-18 H. E. W. D. Enterprises-America, Inc. Gasoline fuel additive
US6217578B1 (en) 1999-10-19 2001-04-17 Stryker Spine S.A. Spinal cross connector
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
US9249187B2 (en) 2009-01-28 2016-02-02 Epimmune Inc. Pan-DR binding polypeptides and uses thereof
US20110165037A1 (en) * 2010-01-07 2011-07-07 Ismagilov Rustem F Interfaces that eliminate non-specific adsorption, and introduce specific interactions
GB201022147D0 (en) 2010-12-31 2011-02-16 Immune Targeting Systems Its Ltd Formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133908A (en) * 1959-09-01 1964-05-19 Howard B Klevens Protection of proteins against denaturation by fluorinated aliphatic compounds
US4228274A (en) * 1976-09-28 1980-10-14 Merck & Co., Inc. 1-Substituted glycopyranosides
US4259324A (en) * 1979-07-31 1981-03-31 Merck & Co., Inc. Immunologic adjuvant thio glycoside compounds and compositions
US4301152A (en) * 1979-10-26 1981-11-17 Merck & Co., Inc. Immunologic adjuvant
US4433051A (en) * 1981-10-14 1984-02-21 Yeda Research And Development Co., Ltd. Derivatives of α-difluoromethylornithine useful in analysis
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
FR2602774B1 (fr) * 1986-07-29 1990-10-19 Atta Nouvelles molecules amphiphiles polyhydroxylees et perfluoroalkylees ayant des proprietes tensioactives

Also Published As

Publication number Publication date
DE68906279D1 (de) 1993-06-09
EP0327070A1 (de) 1989-08-09
JPH01294698A (ja) 1989-11-28
DE68906279T2 (de) 1993-08-12
EP0327070B1 (de) 1993-05-05
US5055562A (en) 1991-10-08

Similar Documents

Publication Publication Date Title
KR840003815A (ko) 효소와 항체의 공유결합에 의해 결합된 접합체의 제조방법
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE69121844D1 (de) Immunotest für Cyclosporin
KR850002961A (ko) 메탈로티오나인 및 표적탐색용 생물학적 활성분자의 추적-표지된 접합체의 제조방법
ATE88901T1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
DK0484369T3 (da) Modificerede bioluminescerende proteiner og anvendelse deraf
IL89823A0 (en) Antibody hetero conjugates and pharmaceutical compositions containing them
DE3687779D1 (de) Trichotecenkonjugate.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
DK0407813T3 (da) Oxidativ denaturering af proteinanalytter
ES2148144T3 (es) Procedimiento para la estabilizacion de conjugados de enzima.
FR2434392B1 (de)
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
DK314886A (da) Histamin-derivat og -immunogen-konjugat, cellelinie og antistof produceret deraf samt immunbestemmelse af histamin ved hjaelp af antistoffet
DE69014300D1 (de) Radioaktive markierung von proteinen.
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
EP0539584A4 (de)
ES2045387T3 (es) Metodo de demostrar virus de enfermedad de marek en aves de corral.
KR860008779A (ko) 항체 형성 화합물의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties